代谢工程
分区(防火)
合成生物学
生化工程
代谢途径
焊剂(冶金)
计算生物学
工程类
生物
萜类
生物化学
化学
酶
有机化学
作者
Γεώργιος Δαλέτος,Constantinos Katsimpouras,Gregory Stephanopoulos
标识
DOI:10.1016/j.tibtech.2020.03.009
摘要
Coculture systems can accommodate complex pathways that are difficult to engineer in a single cell. Mutualistic growth between the consortia members has been a successful strategy to maintain stable coculture systems. Protein engineering has been used as a complementary approach to increase the pathway flux in case there is a limited catalytic activity of the wild type enzymes. De novo entry pathways circumvent limitations associated with the native isoprenoid pathways, facilitating the optimization of cell growth and isoprenoid production. Enhanced formation of lipid bodies within the host leads to higher isoprenoid titers owing to increased storage capacity and solubility. The development of cell-free platforms is an emerging strategy offering manifold advantages, such as the precise control of reaction conditions and the absence of product toxicity. Metabolic engineering has emerged as an important tool for reconstructing heterologous isoprenoid metabolic pathways in microbial hosts. Here, we provide an overview of promising engineering strategies that have proven to be successful for the high-yield production of isoprenoids. Besides 'conventional' approaches, such as the 'push–pull' and protein engineering to optimize the isoprenoid flux and limited catalytic activity of enzymes, we review emerging strategies in the field, including compartmentalization between synthetic consortia members, novel bypass pathways for isoprenoid synthesis, cell-free systems, and improvement of the lipid content to overcome storage isoprenoid limitations. Pitfalls, along with lessons learned from the application of these strategies, will be addressed with the hope of guiding future efforts toward cost-effective and sustainable production of isoprenoids. Metabolic engineering has emerged as an important tool for reconstructing heterologous isoprenoid metabolic pathways in microbial hosts. Here, we provide an overview of promising engineering strategies that have proven to be successful for the high-yield production of isoprenoids. Besides 'conventional' approaches, such as the 'push–pull' and protein engineering to optimize the isoprenoid flux and limited catalytic activity of enzymes, we review emerging strategies in the field, including compartmentalization between synthetic consortia members, novel bypass pathways for isoprenoid synthesis, cell-free systems, and improvement of the lipid content to overcome storage isoprenoid limitations. Pitfalls, along with lessons learned from the application of these strategies, will be addressed with the hope of guiding future efforts toward cost-effective and sustainable production of isoprenoids. catalyzes the formation of acetoacetyl-CoA from acetyl-CoA. catalyzes the ligation of acetate and coenzyme A (CoA) to form acetyl-CoA. a cascade of enzymatic reactions in vitro employed to convert a substrate into a product. catalyzes the dephosphorylation of orthophosphoric monoesters. It shows broad specificity and can also catalyze the phosphorylation of a wide range of hydroxy compounds. grams of product per gram of dry cell weight. dry cell weight. diacylglycerol O-acyltransferase 1; catalyzes the terminal step of triacylglycerol (TAG) formation. catalyzes the prenylation of l-tryptophan to dimethylallyl-l-tryptophan in the presence of DMAPP. farnesyl diphosphate synthase; catalyzes the sequential condensation of isopentenyl diphosphate with dimethylallyl diphosphate and geranyl diphosphate to form farnesyl diphosphate. catalyzes the formation of a C–C double bond at a specific position of a fatty acid chain. the phenomenon where the end product of an enzymatic reaction inhibits the activity of the enzyme. the study of metabolite fluxes through metabolic networks. enzyme that catalyzes the phosphorylation of 4-methyl-5-(2-hydroxyethyl)thiazole. catalyzes the phosphorylation of IP and DMAP to IPP and DMAPP, respectively. catalyzes the conversion of IPP to DMAPP and vice versa. (droplets); cellular organelles for the storage of neutral lipids. the systematic study of metabolites within a biological specimen. a strategy to optimize metabolic pathways and strains involving the separation of key enzymes into modules to balance the flux through a pathway. a term to describe the improved growth of a distinct microbial population as a result of mutual interaction with other microbial populations. grams of product per liter of culture volume per hour. a DNA sequence that defines where the transcription of a gene by RNA polymerase begins. enzymes that catalyze a rate-limiting step (the slowest step) of a metabolic pathway. a nonenzymatic protein involved in lipid droplet formation. grams of product per liter of culture volume. the N-terminal truncated form of 3-hydroxy-3-methyl-glutaryl-coenzyme A (HMG-CoA) reductase; catalyzes the conversion of HMG-CoA to mevalonate. grams of product per gram of carbon substrate consumed.
科研通智能强力驱动
Strongly Powered by AbleSci AI